SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-671006
Filing Date
2016-08-04
Accepted
2016-08-04 08:07:29
Documents
65
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d220290d10q.htm 10-Q 547542
2 EX-31(I).1 d220290dex311.htm EX-31.1 5864
3 EX-31(I).2 d220290dex312.htm EX-31.2 6025
4 EX-32.1 d220290dex321.htm EX-32.1 3226
5 EX-32.2 d220290dex322.htm EX-32.2 3403
  Complete submission text file 0001193125-16-671006.txt   3444963

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT jnp-20160630.xml EX-101.INS 695917
7 XBRL TAXONOMY EXTENSION SCHEMA jnp-20160630.xsd EX-101.SCH 39516
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE jnp-20160630_cal.xml EX-101.CAL 62710
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE jnp-20160630_def.xml EX-101.DEF 117226
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE jnp-20160630_lab.xml EX-101.LAB 312047
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jnp-20160630_pre.xml EX-101.PRE 220232
Mailing Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110
Business Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110 617-639-1500
JUNIPER PHARMACEUTICALS INC (Filer) CIK: 0000821995 (see all company filings)

IRS No.: 592758596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10352 | Film No.: 161805869
SIC: 2834 Pharmaceutical Preparations